DOJ Has Dismissed Lawsuit Against Pfizer Concerning Its Fraudulent COVID Jab “Clinical Trial”
Pfizer Whistleblower Brook Jackson explains how Trump’s DOJ has dismissed her lawsuit against Pfizer concerning its fraudulent COVID-jab “clinical trial.”
Pfizer Whistleblower Brook Jackson explains how Trump’s DOJ has dismissed her lawsuit against Pfizer concerning its fraudulent COVID-jab “clinical trial.”
The DOJ said her case “lacks merit” and “does not align with public health policy.” “The Biden administration had access to the same data that Trump does,” Jackson says.
“The two administrations have held the same position. Nothing has changed.”
This clip of Jackson in top link is from a recent interview with The Last American Vagabond.
Fluoride is added to public drinking water under the premise of preventing dental decay. However, emerging scientific evidence and legal developments have raised concerns about its safety and efficacy. Notably, a federal court ruling in September 2024 determined that water fluoridation poses an unreasonable risk to human health, particularly for children and other vulnerable populations.
While the science continues to evolve—and increasingly supports halting fluoridation—the core issue transcends the scientific debate: adding fluoride to public water is a form of mass medication administered without individual consent. Regardless of differing views on efficacy, every person deserves the right to choose what substances enter their body, especially through something as essential and unavoidable as drinking water.
This toolkit is designed to empower advocates and community leaders with the knowledge and resources needed to challenge and end water fluoridation practices in their localities. It provides guidance on understanding the current status of fluoridation in your area, engaging with policymakers, and mobilizing community support.
Ready to advocate for the removal of fluoride in your town? We have made it incredibly easy.
If you are an advocate helping the initiative, click here and scroll down to the important graphics and documents to help prepare you to speak or educate others.
Step One: Find Out If Your State Mandates, Bans, or Defers to Local Control
STEP TWO: 5 emails to send your elected officials
Use these templates to easily draft personalized letters advocating for fluoride removal from your county water supply. Simply download the document, customize the content with your specific details, local research, and personal perspective, then send it to your local county officials to request a meeting and discuss the potential health risks associated with water fluoridation.
STEP 3: Use these Important documents and resources to inform yourself and your policymaker
This case involved a 25-year-old woman who experienced progressive numbness and tingling, beginning in her torso and eventually affecting her entire body. Over a four-week period, her neurological symptoms worsened, including a decrease in her reflexes (hyporeflexia), prompting her to seek care at a neurology clinic. Notably, she lacked the hallmark features typically associated with Lyme disease.
Instead, her clinical presentation was dominated by decreased reflexes (hyporeflexia) and sensory disturbances. Symptoms initially localized to the hypogastric region gradually radiated to her back and extremities.
“The numbness and tingling began on the right side of her stomach and radiated to her back and later spread to her entire body. The tingling was not associated with any burning or pins-and-needles sensation,” the authors wrote.¹
Alarming Progression of Symptoms
The symptoms significantly impaired her daily functioning, including her ability to care for her child.
“She especially became alarmed when she could not hold her toddler anymore and ended up dropping the child secondary to her numbness and tingling,” the authors reported.
Neurological Findings
A motor examination revealed:
Decreased muscle tone, more pronounced in the upper limbs (3/5 strength) than in the lower limbs (4/5 strength)
Hyporeflexia in the biceps, triceps, patellar, and Achilles tendons
Diagnostic Workup
A lumbar puncture revealed an elevated protein concentration in cerebrospinal fluid (148 mg/dL; normal range: 15–60 mg/dL), suggesting central nervous system involvement. The diagnosis of Lyme disease was confirmed via Western blot testing.
Comparison to Logigian and Steere’s Findings
This case contrasts with findings from the 1990 study by Logigian and Steere published in The New England Journal of Medicine, which evaluated 27 patients with chronic neurologic Lyme disease. In that study, 25 of 27 patients (93%) had normal CSF results, including normal protein levels and no pleocytosis.²
This discrepancy underscores a key point: while CSF abnormalities may support the diagnosis of neurologic Lyme disease, their absence does not rule it out. The variability in neurological presentations highlights the importance of clinical judgment.
Treatment and Outcome
The patient was initially treated with intravenous ceftriaxone for three days, followed by oral doxycycline. Her response to treatment was both rapid and substantial. Upon discharge:
• She regained full spontaneous movement in all extremities.
• Her gait had normalized.
“At the time of discharge, the patient was able to move all extremities spontaneously and ambulate with a normal gait,” the authors noted.
Four Key Discussion Points
1. Neurological Manifestations of Lyme Disease
This case reinforces the importance of recognizing the diverse neurological presentations of Lyme disease. As shown in the Logigian and Steere study, the absence of CSF abnormalities is not uncommon in chronic neurologic Lyme. Clinicians should consider Lyme disease even when classic signs are absent.
2. Role of Lumbar Puncture in Diagnosis
Although this patient had elevated CSF protein levels, many patients with neurologic Lyme disease may have normal CSF results. This highlights the need to use a combination of clinical history, physical exam, and serological testing to make the diagnosis.
3. Timely Diagnosis and Treatment
Despite a delay in diagnosis, the patient responded well to antibiotics. The treatment regimen—IV ceftriaxone followed by oral doxycycline—is effective in managing Lyme neuroborreliosis.
4. Impact on Quality of Life
The patient’s neurological symptoms significantly affected her ability to care for her child. Early recognition and treatment are vital to restoring function and preserving quality of life.
Conclusion
Timely diagnosis and treatment of Lyme neuroborreliosis can lead to excellent outcomes, even in patients with atypical presentations. This case emphasizes the importance of clinical awareness and early intervention in restoring function and providing reassurance.
The recently established Chemtrails Task Force of the Trump administration is not wasting any time.
As confirmed by insiders, the National Oceanic and Atmospheric Administration, or NOAA, has been operating rogue chemtrails out of covert sub-departments.
The problem is that’s only the beginning. Because what the task group discovered next is far more sinister—and includes foreign countries, weather systems that have been weaponized, and a long-standing scheme to manipulate the bodies and minds of a whole population.
Independent labs are analyzing samples, and initial findings are alarming.
The dust contains a toxic mix—barium, strontium, aluminum, lead, cadmium, and traces of Ba-137, a radioactive isotope linked to nuclear activity.
To be clear: this is evidence of nuclear transmutation.
Are Flu ‘Pandemics’ Caused by the Army Spraying Chemical Agents From Airplanes?
“The 1957 Asian flu pandemic was announced…after this ‘large area coverage’ spraying by the U.S. Army…CDC came in and said, ‘There’s a new virus.’ … Does this sound familiar?”
“The 1957 Asian flu pandemic was announced…after this ‘large area coverage’ spraying by the U.S. Army…CDC came in and said, ‘There’s a new virus.’ … Does this sound familiar?”
Retired pharma R&D executive Sasha Latypova describes for Dr. Jane Ruby during a recently posted interview on The Dr. Jane Ruby Show how the spraying of chemical agents from U.S. Army airplanes has been associated with respiratory illnesses. Latypova highlights one instance from the late 1950s when the CDC declared an ostensible outbreak of so-called “Asian flu pandemic” in the U.S. closely following a cross-country spraying campaign conducted by the Army.
Latypova notes that Adams found zinc cadmium sulfide (ZnCdS)—a compound formed by a mixture of zinc sulfide (ZnS) and cadmium sulfide (CdS)— in Ruby’s sample and that this exact compound was sprayed by the Army in the ’50s and ’60s.
“Interestingly,” Latypova says, “the Army used these fluorescent particles as a test of dispersals in numerous tests over the years. One of the largest ones they did was called ‘large area coverage operation’ or ‘operation LAC.’ And in this operation they flew thousands of flights that crisscrossed the entire United States.
This was to disperse these particles all over the United States in 1957. They started, interestingly, on December 2nd, 1957, went through the winter season of ’57 to ’58, flew all over U.S. [and] dispersed the particles. And, interestingly, in that season, we had [a] so-called ‘Asian flu pandemic.'”
The continued use of mRNA vaccines in the United States remains one of the most politically and medically contentious issues of our time. As public awareness grows around adverse event profiles and the questionable regulatory processes that ushered these products into global use, many are now asking an urgent question: why hasn’t HHS Secretary Robert F. Kennedy Jr. acted to revoke them?
To the untrained observer, Kennedy’s hesitation might appear as political caution or betrayal of his vaccine-critical roots. But the reality is far more complex. Pulling a product authorized under Emergency Use Authorization (EUA) or granted full Biologics License Application (BLA) approval is not a matter of executive decree. It requires a coordinated, multi-agency reckoning with evidence, policy, and law. And the legal scaffolding built to protect vaccine manufacturers—particularly under the Public Readiness and Emergency Preparedness (PREP) Act—was designed precisely to prevent the kind of abrupt retraction the public is demanding.
Yet the fortress is beginning to crumble.
The Nature of the Authorizations
Most Americans believe the mRNA vaccines are “approved.” In fact, the vaccines administered to the majority of the population have remained under EUA, not full licensure. The FDA granted BLAs to Comirnaty (Pfizer) and Spikevax (Moderna), but those exact products are often not available in the U.S. commercial supply chain. This bait-and-switch has significant legal implications, particularly around informed consent and product liability.
Under 21 U.S.C. § 360bbb-3, EUA requires that the Secretary of HHS determine that there is a public health emergency, that no adequate approved alternatives exist, and that the known and potential benefits outweigh the known and potential risks. But what happens when emerging data calls that balance into question?
What It Has Taken to Pull Vaccines Before
History tells us that only under grave circumstances does the FDA pull a vaccine. The Cutter Incident in 1955, in which live polio virus in inactivated vaccine batches caused paralytic disease and death, is one example. RotaShield, pulled in 1999 after being linked to intussusception in infants, is another. Pandemrix, used during the 2009 H1N1 pandemic, was withdrawn in Europe after post-vaccine narcolepsy cases.
But unlike those cases, mRNA vaccine injuries are statistically diffuse, often delayed, and obscured by passive surveillance systems with notorious underreporting. (See link for article)
_______________
Important quote:
The regulators knew. The manufacturers knew. And, in time, the record will show who acted—and who remained silent. ~ Dr. James Lyons Weiler
The article discusses the sweeping liability protection to ‘vaccine’ manufacturers called The Prep Act and that The Supreme Court could soon be asked whether HHS may revoke these immunities if the product’s risk-benefit profile is no longer defensible. It also discusses the replacement of Peter Marks, who remained resistant to transparency to the bitter end, with Vinay Prasad, who is known for his rigorous critique of Pharma-captured science and his opposition to the inclusion of the COVID shots on the routine childhood schedule.
It was enjoyable to watch Prasad become more and more vocal after he swallowed the red pill. At the end, he was stating,
Do not test, do not report cases, do not wear masks, do not take the shots.
Quite a turnaround.
He also had no trouble taking Walensky down, pointing out her repeated LIES, and stating the CDC abandoned science. It was actually fun watching him go from a short-haired, square cornered, believe the ‘experts’ type doctor to a long haired, beard wearing, bloody honest doctor who in the end despises what public health has become. Bravo!
In this eye-opening interview, I sit down with embalmer Richard Hirschman and industrial chemist Greg Harrison to investigate the emergence of large, white fibrous clots in deceased individuals who received COVID-19 mRNA injections.
Hirschman, a seasoned embalmer with over 20 years of experience, first began noticing these unusual white, rubbery clots in early 2021. Found in both veins and arteries—a rarity in embalming practice—their frequency and composition were unlike anything he had encountered in two decades of work.
To better understand what they were made of, he partnered with Greg Harrison, an industrial organic chemist with deep expertise in polymer analysis. Harrison subjected the clots to rigorous biochemical testing using techniques like ICP-MS, HPLC, Raman spectroscopy, and RT-QuIC.
What they uncovered is nothing short of shocking: these are not ordinary post-mortem clots. The structures are composed of misfolded fibrin proteins with amyloid characteristics—including signs of infectious amyloid behavior, capable of triggering misfolding in other proteins. These findings raise grave concerns about a novel, systemic disease process that may be silently affecting millions. (See link for article and video)
________________
**Comment**
These clots were first seen in 2021, after the shot rollout but are now seen in 30-50% of all bodies Hirschman embalms. Similar clots have been removed from living patients during surgery and catheterization. Multiple independent embalmers and pathologists globally are now reporting the same thing and 83% of embalmers have observed these unique clots.
Standard lab panels cannot detect the clots, only specialized imaging using Thioflavin T fluorescence or similar markers can reveal them.
Their discovery that these misfolded fibrin proteins with amyloid characteristics including signs of infectious behavior and triggering misfolding in other proteins is extremely frightening indeed as it raises concerns of a novel, systemic disease process.
Extremely high levels of phosphorus — up to 4,900 ppm, compared to a normal blood range of 100–1,500 ppm.
Deficiency of essential blood elements, including iron, zinc, and magnesium — all typically abundant in red blood.
Dominant presence of fibrinogen beta chain — accounting for over 35% of protein content, while the fibrinogen alpha and gamma chains were severely underrepresented or nearly absent.
No complete fibrils detected — only monomers, indicating incomplete or dysfunctional polymerization of clotting proteins.
High concentrations of proline, an amino acid known to kink and misfold proteins — consistent with the presence of amyloidogenic material and potentially linked to modified codons in mRNA vaccines.
The experts believe there are three possible causes of these clots: synthetic spike protein, lipid nanoparticles, and/or modified codons and proline substitutions.
Madison Area Lyme Support Group 